These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9808698)

  • 1. Effect of YNS-15P, a new alpha-2 adrenoceptor antagonist, on stress-stimulated colonic propulsion in rats.
    Yamamoto O; Niida H; Tajima K; Shirouchi Y; Kyotani Y; Ueda F; Kise M; Kimura K
    J Pharmacol Exp Ther; 1998 Nov; 287(2):691-6. PubMed ID: 9808698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
    Kadowaki M; Nagakura Y; Tomoi M; Mori J; Kohsaka M
    J Pharmacol Exp Ther; 1993 Jul; 266(1):74-80. PubMed ID: 8331576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of stress-stimulated colonic propulsion by alpha 2-adrenoceptor antagonists in rats.
    Yamamoto O; Niida H; Tajima K; Shirouchi Y; Masui Y; Ueda F; Kise M; Kimura K
    Neurogastroenterol Motil; 1998 Dec; 10(6):523-32. PubMed ID: 10050258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alpha-2 adrenoceptor antagonists on colonic function in rats.
    Yamamoto O; Niida H; Tajima K; Tanaka M; Makita Y; Ueda F; Yano J
    Neurogastroenterol Motil; 2000 Jun; 12(3):249-55. PubMed ID: 10867622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
    Funatsu T; Takeuchi A; Hirata T; Keto Y; Akuzawa S; Sasamata M
    Eur J Pharmacol; 2007 Nov; 573(1-3):190-5. PubMed ID: 17658508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome.
    Kishibayashi N; Miwa Y; Hayashi H; Ishii A; Ichikawa S; Nonaka H; Yokoyama T; Suzuki F
    J Med Chem; 1993 Oct; 36(22):3286-92. PubMed ID: 8230119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of GK-128 [2-[(2-methylimidazol-1-yl)methyl]-benzo[f]thiochromen-1-one monohydrochloride hemihydrate], a selective 5-hydroxytryptamine3 receptor antagonist, on colonic function in rats.
    Ito C; Isobe Y; Kawamura R; Kiuchi Y; Tsuchida K; Higuchi S
    J Pharmacol Exp Ther; 1997 Jan; 280(1):67-72. PubMed ID: 8996183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats.
    Ataka K; Kuge T; Fujino K; Takahashi T; Fujimiya M
    Auton Neurosci; 2007 May; 133(2):136-45. PubMed ID: 17182287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer.
    Hirata T; Keto Y; Nakata M; Takeuchi A; Funatsu T; Akuzawa S; Sasamata M; Miyata K
    Neurogastroenterol Motil; 2008 May; 20(5):557-65. PubMed ID: 18221252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats.
    Nakade Y; Fukuda H; Iwa M; Tsukamoto K; Yanagi H; Yamamura T; Mantyh C; Pappas TN; Takahashi T
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1037-44. PubMed ID: 17158256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of trimebutine and YM114 (KAE-393), a novel 5-HT3 receptor antagonist, on stress-induced defecation.
    Miyata K; Ito H; Yamano M; Hidaka K; Kamato T; Nishida A; Yuki H
    Eur J Pharmacol; 1993 Dec; 250(2):303-10. PubMed ID: 8112388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased colonic transit in rats produced by a combination of a cholinesterase inhibitor with a 5-HT4 receptor agonist.
    Campbell-Dittmeyer K; Hicks GA; Earnest DL; Greenwood-Van Meerveld B
    Neurogastroenterol Motil; 2009 Nov; 21(11):1197-e108. PubMed ID: 19210632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride.
    Megens AA; Awouters FH; Niemegeers CJ
    Arzneimittelforschung; 1991 Jun; 41(6):631-4. PubMed ID: 1930352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the serotonin3 receptor in stress-induced defecation.
    Miyata K; Kamato T; Nishida A; Ito H; Yuki H; Yamano M; Tsutsumi R; Katsuyama Y; Honda K
    J Pharmacol Exp Ther; 1992 Apr; 261(1):297-303. PubMed ID: 1560375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide S inhibits stress-stimulated faecal output in the rat.
    Petrella C; Agostini S; Guerrini R; Calò G; Giaquinto A; De Nuccio C; Improta G; Broccardo M
    Pharmacol Res; 2011 Nov; 64(5):471-7. PubMed ID: 21708257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the antidiarrhoeal effect of Sanseviera liberica Gerome & Labroy (Agavaceae) root extract.
    Adeyemi OO; Akindele AJ; Ogunleye EA
    J Ethnopharmacol; 2009 Jun; 123(3):459-63. PubMed ID: 19481383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peristalsis and fecal pellet propulsion do not require nicotinic, purinergic, 5-HT3, or NK3 receptors in isolated guinea pig distal colon.
    Nicholas S; Spencer NJ
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G952-61. PubMed ID: 20360134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of ramosetron, a novel therapeutic agent for IBS.
    Hirata T; Funatsu T; Keto Y; Nakata M; Sasamata M
    Inflammopharmacology; 2007 Feb; 15(1):5-9. PubMed ID: 17323187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents.
    Hirata T; Funatsu T; Keto Y; Akuzawa S; Sasamata M; Miyata K
    J Pharmacol Sci; 2008 Feb; 106(2):264-70. PubMed ID: 18296863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laxative and anti-diarrheal activity of polycarbophil in mice and rats.
    Saito T; Mizutani F; Iwanaga Y; Morikawa K; Kato H
    Jpn J Pharmacol; 2002 Jun; 89(2):133-41. PubMed ID: 12120755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.